Aegis Sciences Corporation Announces National Launch of Expanded Novel Psychoactive Substance Testing
July 27, 2020 12:10 ET
|
Aegis Sciences Corporation
NASHVILLE, Tenn., July 27, 2020 (GLOBE NEWSWIRE) -- Aegis Sciences Corporation, a leading healthcare company that provides clinically innovative medication compliance testing and consulting services...
Premera Blue Cross offers zero cost share virtual mental health and substance use disorder treatment during COVID-19 pandemic
April 21, 2020 15:02 ET
|
Premera Blue Cross
Mountlake Terrace, Wash., April 21, 2020 (GLOBE NEWSWIRE) -- Premera Blue Cross, a leading health plan in the Pacific Northwest, today announced an expansion of its zero cost share options for...
athenahealth Hosts Boston Medical Center for Interview Exploring How Data and Insights Will Play a Critical Role in Helping to Reduce Opioid Deaths in the Future
February 24, 2020 09:00 ET
|
athenahealth, Inc.
WATERTOWN, Mass., Feb. 24, 2020 (GLOBE NEWSWIRE) -- athenahealth, Inc., a leading provider of network-enabled services for ambulatory and enterprise customers nationwide, has released a new video...
SPR Therapeutics Announces 1000th Sprint PNS Procedure
December 04, 2019 08:30 ET
|
SPR Therapeutics, Inc.
CLEVELAND, Dec. 04, 2019 (GLOBE NEWSWIRE) -- SPR Therapeutics, Inc., a leader in neurostimulation technology for pain management, announced today the successful commercial placement of its 1000th...
Adynxx Reports Third Quarter 2019 Financial Results
November 14, 2019 06:00 ET
|
Adynxx, Inc.
SAN FRANCISCO, Nov. 14, 2019 (GLOBE NEWSWIRE) -- Adynxx, Inc. (OTCQB: ADYX), a clinical-stage biopharmaceutical company focused on the development of transcription factor decoy technology and...
Inmar’s LifeInCheck Consumer Drug Take-Back Program Works with Hy-Vee to Add Over 200 Additional Drug Disposal Receptacles in Pharmacies in Eight Midwest States
October 25, 2019 09:59 ET
|
Inmar, Inc.
Winston-Salem, NC, Oct. 25, 2019 (GLOBE NEWSWIRE) -- Inmar, a data-driven technology-enabled services company, today announced that Hy-Vee, Inc. – an employee-owned supermarket chain – will place...
National Addiction Treatment Week Highlights the Critical Need for the Medical Community to Treat Addiction
October 21, 2019 08:39 ET
|
American Society of Addiction Medicine
Rockville, MD, Oct. 21, 2019 (GLOBE NEWSWIRE) -- Each year, National Addiction Treatment Week (NATW) raises awareness that addiction is a disease, evidence-based treatments are available, and...
Adynxx Receives NIH HEAL Initiative Funding Award for Development of Second Non-Opioid Pain Therapeutic
October 02, 2019 08:00 ET
|
Adynxx, Inc.
SAN FRANCISCO, Oct. 02, 2019 (GLOBE NEWSWIRE) -- Adynxx, Inc. (OTCQB: ADYX), a clinical-stage biopharmaceutical company focused on the development of transcription factor decoy technology and...
NOTICE TO DISREGARD – Progressive Care Inc.
September 12, 2019 17:17 ET
|
Progressive Care, Inc.
MIAMI, Sept. 12, 2019 (GLOBE NEWSWIRE) -- We are advised by Progressive Care, Inc. that journalists and other readers should disregard the news release, Progressive Care Inc. Subsidiaries PharmCo...
Endonovo Therapeutics Appoints Dr. Geoffrey Abrams of Stanford University to Its Scientific Advisory Board
August 30, 2019 09:00 ET
|
Endonovo Therapeutics Inc.
LOS ANGELES, Aug. 30, 2019 (GLOBE NEWSWIRE) -- via NetworkWire -- Endonovo Therapeutics Inc. (OTCQB: ENDV) ("Endonovo" or the "Company"), a commercial-stage developer of noninvasive Electroceutical®...